Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Endocrine differentiation in basocellular carcinoma].

G Collina1, L Macrì, V Eusebi

  • 1Dipartimento di Oncologia, Sezione di Anatomia, Istologia e Citologia Patologica M. Malpighi, Ospedale Bellaria, Via Altura 3, I-40139 Bologna. Guido.Collina@AUSL.Bologna.it

Pathologica
|July 4, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Goiter in the models of Pre-Raphaelite Brotherhood.

Journal of endocrinological investigation·2021
Same author

Ancient dwarves from Tunisia.

Journal of endocrinological investigation·2021
Same author

A case of thyroidectomy in the Charaf ed-Din's manuscript (1465).

Journal of endocrinological investigation·2020
Same author

The baptism of the Princes of Marseille Gaudenzio Ferrari (1475-1546).

Journal of endocrinological investigation·2017
Same author

Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?

Neuro-oncology practice·2015
Same author

Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role?

Annals of surgical oncology·2014

Basal cell carcinoma (BCC) exhibits endocrine differentiation, confirmed by detecting chromogranin A messenger RNA (mRNA) using reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry in multiple BCC cases.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatopathology

Context:

  • Basal cell carcinoma (BCC) is the most common type of human cancer.
  • Endocrine differentiation in BCC has been suggested but requires molecular confirmation.
  • Chromogranin A is a well-established marker for neuroendocrine differentiation.

Purpose:

  • To investigate the presence and extent of endocrine differentiation in basal cell carcinoma.
  • To utilize both immunohistochemistry and molecular techniques (RT-PCR) for sensitive detection.
  • To confirm the expression of chromogranin A mRNA and protein in BCC.

Summary:

  • Three propositus cases of BCC were analyzed for chromogranin A mRNA via RT-PCR, yielding positive results.
  • An additional 20 BCC cases were assessed using immunohistochemistry for chromogranin A, synaptophysin, S100 protein, cytokeratin 20, and neuron-specific enolase (NSE).

Related Experiment Videos

  • Focal positivity for chromogranin A was observed in 11 of the 20 consecutive BCC cases, supporting endocrine differentiation.

    • Impact:

    • Provides robust evidence for endocrine differentiation in basal cell carcinoma.
    • Highlights the utility of chromogranin A as a marker in BCC.
    • Enhances understanding of BCC heterogeneity and potential therapeutic targets.